GlycoMimetics, Inc. (GLYC)
NASDAQ: GLYC · IEX Real-Time Price · USD
1.855
+0.020 (1.09%)
At close: Apr 24, 2024, 4:00 PM
1.889
+0.034 (1.83%)
After-hours: Apr 24, 2024, 7:57 PM EDT
GlycoMimetics Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for GlycoMimetics stock have an average target of 10, with a low estimate of 8.00 and a high estimate of 12. The average target predicts an increase of 439.08% from the current stock price of 1.86.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for GlycoMimetics stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Buy | 0 | 1 | 1 | 1 | 1 | 1 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 1 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $8 | Strong Buy | Maintains | $8 | +331.27% | Mar 27, 2024 |
Capital One | Capital One | Buy Initiates $12 | Buy | Initiates | $12 | +546.90% | Dec 22, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +331.27% | Aug 3, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +331.27% | Jun 15, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +331.27% | May 4, 2023 |
Financial Forecast
Revenue This Year
n/a
from 10.00K
Revenue Next Year
29.31M
EPS This Year
-0.62
from -0.58
EPS Next Year
-0.46
from -0.62
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | n/a | 59.7M | 195.2M | 358.2M | 528.3M |
Avg | n/a | 29.3M | 112.2M | 180.8M | 265.1M |
Low | n/a | 1.7M | 56.1M | 26.4M | 59.6M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | 566.0% | 219.2% | 192.2% |
Avg | - | - | 282.9% | 61.1% | 46.6% |
Low | - | - | 91.4% | -76.5% | -67.0% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -0.59 | 0.08 | 1.34 | 2.53 | 3.58 |
Avg | -0.62 | -0.46 | 0.50 | 2.46 | 3.48 |
Low | -0.67 | -0.89 | 0.04 | 2.36 | 3.34 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | 409.8% | 45.7% |
Avg | - | - | - | 395.2% | 41.5% |
Low | - | - | - | 375.8% | 35.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.